{"transactions":[{"id":792764,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2026-05-05T22:21:13.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth of the shares subject to the award vested on March 10, 2026; the remaining shares will vest monthly, starting on June 10, 2026, subject to the reporting person's continued service on each such date, until the award is fully vested on March 10, 2029."}],"balance_after":110000,"derivative":{"exercise_price":0.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001477932-26-002770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002770/form4.xml","form_type":"4"}},{"id":792763,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-05-05T22:21:13.000Z","date":"2026-03-01","kind":"other","planned":false,"acquired":false,"shares":900000,"price":0.3,"value":270000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"900,000 warrants to purchase shares of common stock with an exercise price of $0.30, with an issuance date of March 1, 2023, expired on March 1, 2026, without being exercised."}],"balance_after":2700000,"derivative":{"exercise_price":0.3,"exercise_date":"2023-03-01","expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001477932-26-002770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002770/form4.xml","form_type":"4"}},{"id":792762,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-05-05T22:21:13.000Z","date":"2026-02-25","kind":"exercise","planned":false,"acquired":false,"shares":1000000,"price":0.2,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"During February 2026, Mr. Blumberg entered into an exchange agreement pursuant to which 1,000,000 warrants to purchase shares of common stock with an exercise price of $0.50 were exchanged for 1,000,000 warrants with an exercise price of $0.20. The newly issued warrants were immediately exercised upon payment of $200,000. In connection with the exchange agreement, the expiration date of 1,000,000 warrants with an exercise price of $0.65 was extended for one year, until September 1, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During February 2026, Mr. Blumberg entered into an exchange agreement pursuant to which 1,000,000 warrants to purchase shares of common stock with an exercise price of $0.50 were exchanged for 1,000,000 warrants with an exercise price of $0.20. The newly issued warrants were immediately exercised upon payment of $200,000. In connection with the exchange agreement, the expiration date of 1,000,000 warrants with an exercise price of $0.65 was extended for one year, until September 1, 2027."}],"balance_after":0,"derivative":{"exercise_price":0.2,"exercise_date":"2026-02-25","expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001477932-26-002770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002770/form4.xml","form_type":"4"}},{"id":792761,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-05-05T22:21:13.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"During February 2026, Mr. Blumberg entered into an exchange agreement pursuant to which 1,000,000 warrants to purchase shares of common stock with an exercise price of $0.50 were exchanged for 1,000,000 warrants with an exercise price of $0.20. The newly issued warrants were immediately exercised upon payment of $200,000. In connection with the exchange agreement, the expiration date of 1,000,000 warrants with an exercise price of $0.65 was extended for one year, until September 1, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During February 2026, Mr. Blumberg entered into an exchange agreement pursuant to which 1,000,000 warrants to purchase shares of common stock with an exercise price of $0.50 were exchanged for 1,000,000 warrants with an exercise price of $0.20. The newly issued warrants were immediately exercised upon payment of $200,000. In connection with the exchange agreement, the expiration date of 1,000,000 warrants with an exercise price of $0.65 was extended for one year, until September 1, 2027."}],"balance_after":1000000,"derivative":{"exercise_price":0.2,"exercise_date":"2026-02-25","expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001477932-26-002770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002770/form4.xml","form_type":"4"}},{"id":792760,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-05-05T22:21:13.000Z","date":"2026-02-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"During February 2026, Mr. Blumberg entered into an exchange agreement pursuant to which 1,000,000 warrants to purchase shares of common stock with an exercise price of $0.50 were exchanged for 1,000,000 warrants with an exercise price of $0.20. The newly issued warrants were immediately exercised upon payment of $200,000. In connection with the exchange agreement, the expiration date of 1,000,000 warrants with an exercise price of $0.65 was extended for one year, until September 1, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During February 2026, Mr. Blumberg entered into an exchange agreement pursuant to which 1,000,000 warrants to purchase shares of common stock with an exercise price of $0.50 were exchanged for 1,000,000 warrants with an exercise price of $0.20. The newly issued warrants were immediately exercised upon payment of $200,000. In connection with the exchange agreement, the expiration date of 1,000,000 warrants with an exercise price of $0.65 was extended for one year, until September 1, 2027."}],"balance_after":0,"derivative":{"exercise_price":0.5,"exercise_date":"2022-09-01","expiration_date":"2026-09-01","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001477932-26-002770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002770/form4.xml","form_type":"4"}},{"id":792759,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-05-05T22:21:13.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"During February 2026, Mr. Blumberg entered into an exchange agreement pursuant to which 1,000,000 warrants to purchase shares of common stock with an exercise price of $0.50 were exchanged for 1,000,000 warrants with an exercise price of $0.20. The newly issued warrants were immediately exercised upon payment of $200,000. In connection with the exchange agreement, the expiration date of 1,000,000 warrants with an exercise price of $0.65 was extended for one year, until September 1, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During February 2026, Mr. Blumberg entered into an exchange agreement pursuant to which 1,000,000 warrants to purchase shares of common stock with an exercise price of $0.50 were exchanged for 1,000,000 warrants with an exercise price of $0.20. The newly issued warrants were immediately exercised upon payment of $200,000. In connection with the exchange agreement, the expiration date of 1,000,000 warrants with an exercise price of $0.65 was extended for one year, until September 1, 2027."}],"balance_after":1000000,"derivative":{"exercise_price":0.65,"exercise_date":"2026-02-25","expiration_date":"2027-09-01","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001477932-26-002770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002770/form4.xml","form_type":"4"}},{"id":792758,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-05-05T22:21:13.000Z","date":"2026-02-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"During February 2026, Mr. Blumberg entered into an exchange agreement pursuant to which 1,000,000 warrants to purchase shares of common stock with an exercise price of $0.50 were exchanged for 1,000,000 warrants with an exercise price of $0.20. The newly issued warrants were immediately exercised upon payment of $200,000. In connection with the exchange agreement, the expiration date of 1,000,000 warrants with an exercise price of $0.65 was extended for one year, until September 1, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During February 2026, Mr. Blumberg entered into an exchange agreement pursuant to which 1,000,000 warrants to purchase shares of common stock with an exercise price of $0.50 were exchanged for 1,000,000 warrants with an exercise price of $0.20. The newly issued warrants were immediately exercised upon payment of $200,000. In connection with the exchange agreement, the expiration date of 1,000,000 warrants with an exercise price of $0.65 was extended for one year, until September 1, 2027."}],"balance_after":0,"derivative":{"exercise_price":0.65,"exercise_date":"2022-09-01","expiration_date":"2026-09-01","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001477932-26-002770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002770/form4.xml","form_type":"4"}},{"id":792757,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-05T22:21:13.000Z","date":"2026-03-26","kind":"other","planned":false,"acquired":true,"shares":352000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"On March 26, 2026, Mr. Blumberg converted 88 shares of Series F-2 preferred stock into 352,000 shares of common stock. The Series F-2 preferred stock had a stated value of $1,000 and $0.25 conversion price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On March 26, 2026, Mr. Blumberg converted 88 shares of Series F-2 preferred stock into 352,000 shares of common stock. The Series F-2 preferred stock had a stated value of $1,000 and $0.25 conversion price."}],"balance_after":10391311,"source":{"system":"sec-edgar","filing":"0001477932-26-002770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002770/form4.xml","form_type":"4"}},{"id":792756,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series F-2 Stock","published_at":"2026-05-05T22:21:13.000Z","date":"2026-03-26","kind":"other","planned":false,"acquired":false,"shares":88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"On March 26, 2026, Mr. Blumberg converted 88 shares of Series F-2 preferred stock into 352,000 shares of common stock. The Series F-2 preferred stock had a stated value of $1,000 and $0.25 conversion price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On March 26, 2026, Mr. Blumberg converted 88 shares of Series F-2 preferred stock into 352,000 shares of common stock. The Series F-2 preferred stock had a stated value of $1,000 and $0.25 conversion price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001477932-26-002770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002770/form4.xml","form_type":"4"}},{"id":792755,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-05T22:21:13.000Z","date":"2026-03-26","kind":"other","planned":false,"acquired":true,"shares":19038,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series F-2 preferred stock, at a conversion price of $0.2773."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series F-2 preferred stock, at a conversion price of $0.2773."}],"balance_after":10039311,"source":{"system":"sec-edgar","filing":"0001477932-26-002770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002770/form4.xml","form_type":"4"}},{"id":792754,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-05T22:21:13.000Z","date":"2026-03-26","kind":"other","planned":false,"acquired":true,"shares":1040000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On March 26, 2026, Mr. Blumberg converted 260 shares of Series F preferred stock into 1,040,000 shares of common stock. The Series F preferred stock had a stated value of $1,000 and $0.25 conversion price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On March 26, 2026, Mr. Blumberg converted 260 shares of Series F preferred stock into 1,040,000 shares of common stock. The Series F preferred stock had a stated value of $1,000 and $0.25 conversion price."}],"balance_after":10020273,"source":{"system":"sec-edgar","filing":"0001477932-26-002770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002770/form4.xml","form_type":"4"}},{"id":792753,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series F Stock","published_at":"2026-05-05T22:21:13.000Z","date":"2026-03-26","kind":"other","planned":false,"acquired":false,"shares":260,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On March 26, 2026, Mr. Blumberg converted 260 shares of Series F preferred stock into 1,040,000 shares of common stock. The Series F preferred stock had a stated value of $1,000 and $0.25 conversion price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On March 26, 2026, Mr. Blumberg converted 260 shares of Series F preferred stock into 1,040,000 shares of common stock. The Series F preferred stock had a stated value of $1,000 and $0.25 conversion price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001477932-26-002770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002770/form4.xml","form_type":"4"}},{"id":792752,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-05T22:21:13.000Z","date":"2026-03-26","kind":"other","planned":false,"acquired":true,"shares":56093,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.2773."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.2773."}],"balance_after":8980273,"source":{"system":"sec-edgar","filing":"0001477932-26-002770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002770/form4.xml","form_type":"4"}},{"id":792751,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-05T22:21:13.000Z","date":"2026-02-25","kind":"exercise","planned":false,"acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During February 2026, Mr. Blumberg entered into an exchange agreement pursuant to which 1,000,000 warrants to purchase shares of common stock with an exercise price of $0.50 were exchanged for 1,000,000 warrants with an exercise price of $0.20. The newly issued warrants were immediately exercised upon payment of $200,000. In connection with the exchange agreement, the expiration date of 1,000,000 warrants with an exercise price of $0.65 was extended for one year, until September 1, 2027."}],"balance_after":8924180,"source":{"system":"sec-edgar","filing":"0001477932-26-002770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002770/form4.xml","form_type":"4"}},{"id":1047113,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2025-09-05T20:03:35.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth of the shares are subject to the award vested on June 3, 2025; the remaining shares will vest monthly, starting on September 3, 2025, subject to the reporting person's continued service on each such date, until the award is fully vested on June 2, 2028."}],"balance_after":110000,"derivative":{"exercise_price":0.14,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001477932-25-006522","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793225006522/form4.xml","form_type":"4"}},{"id":1047112,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-05T20:03:35.000Z","date":"2025-08-21","kind":"other","planned":false,"acquired":true,"shares":932000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On August 21, 2025, Mr. Blumberg (WMB Pension Plan fbo Richard Blumberg) converted 233 shares of Series E preferred stock into 932,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On August 21, 2025, Mr. Blumberg (WMB Pension Plan fbo Richard Blumberg) converted 233 shares of Series E preferred stock into 932,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 exercise price."}],"balance_after":7924180,"source":{"system":"sec-edgar","filing":"0001477932-25-006522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793225006522/form4.xml","form_type":"4"}},{"id":1047111,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series E Stock","published_at":"2025-09-05T20:03:35.000Z","date":"2025-08-21","kind":"other","planned":false,"acquired":false,"shares":233,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On August 21, 2025, Mr. Blumberg (WMB Pension Plan fbo Richard Blumberg) converted 233 shares of Series E preferred stock into 932,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On August 21, 2025, Mr. Blumberg (WMB Pension Plan fbo Richard Blumberg) converted 233 shares of Series E preferred stock into 932,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 exercise price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001477932-25-006522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793225006522/form4.xml","form_type":"4"}},{"id":1047110,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-05T20:03:35.000Z","date":"2025-08-21","kind":"other","planned":false,"acquired":true,"shares":81121,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298."}],"balance_after":6992180,"source":{"system":"sec-edgar","filing":"0001477932-25-006522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793225006522/form4.xml","form_type":"4"}},{"id":1047109,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-05T20:03:35.000Z","date":"2025-04-10","kind":"other","planned":false,"acquired":true,"shares":55853,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series F-2 preferred stock, at a conversion price of $0.0943."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series F-2 preferred stock, at a conversion price of $0.0943."}],"balance_after":6911059,"source":{"system":"sec-edgar","filing":"0001477932-25-006522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793225006522/form4.xml","form_type":"4"}},{"id":1047108,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-05T20:03:35.000Z","date":"2025-04-10","kind":"other","planned":false,"acquired":true,"shares":165481,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943."}],"balance_after":6855206,"source":{"system":"sec-edgar","filing":"0001477932-25-006522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793225006522/form4.xml","form_type":"4"}},{"id":1382143,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2024-10-24T16:10:17.000Z","date":"2024-09-01","kind":"other","planned":false,"acquired":true,"shares":900000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The common stock and warrants from the fourth tranche were issued on September 1, 2024 and October 14, 2024, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The common stock and warrants from the fourth tranche were issued on September 1, 2024 and October 14, 2024, respectively."}],"balance_after":3600000,"derivative":{"exercise_price":0.3,"exercise_date":"2024-09-01","expiration_date":"2027-09-01","underlying":"Common shares","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001477932-24-006656","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793224006656/form4.xml","form_type":"4"}},{"id":1382142,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-24T16:10:17.000Z","date":"2024-10-14","kind":"other","planned":false,"acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The common stock and warrants from the fourth tranche were issued on September 1, 2024 and October 14, 2024, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The common stock and warrants from the fourth tranche were issued on September 1, 2024 and October 14, 2024, respectively."}],"balance_after":6689725,"source":{"system":"sec-edgar","filing":"0001477932-24-006656","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793224006656/form4.xml","form_type":"4"}},{"id":1416660,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2024-09-04T23:17:33.000Z","date":"2024-07-09","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the award vested on July 9, 2024; the remaining shares will vest monthly, starting on October 9, 2024, subject to the reporting person's continued service on each such date, until the award is fully vested on July 8, 2027."}],"balance_after":200000,"derivative":{"exercise_price":0.12,"expiration_date":"2034-07-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001477932-24-005518","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793224005518/form4.xml","form_type":"4"}},{"id":1425923,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-22T22:12:50.000Z","date":"2024-08-21","kind":"other","planned":false,"acquired":true,"shares":170563,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1093."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1093."}],"balance_after":6289725,"source":{"system":"sec-edgar","filing":"0001477932-24-005206","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793224005206/form4.xml","form_type":"4"}},{"id":1547195,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2024-04-05T20:46:51.000Z","date":"2024-03-26","kind":"other","planned":false,"acquired":true,"shares":38893,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series F-2 preferred stock, at a conversion price of $0.1361."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series F-2 preferred stock, at a conversion price of $0.1361."}],"balance_after":6119162,"source":{"system":"sec-edgar","filing":"0001477932-24-001900","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793224001900/form4.xml","form_type":"4"}},{"id":1547194,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2024-04-05T20:46:51.000Z","date":"2024-03-26","kind":"other","planned":false,"acquired":true,"shares":114912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.1361."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.1361."}],"balance_after":6080269,"source":{"system":"sec-edgar","filing":"0001477932-24-001900","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793224001900/form4.xml","form_type":"4"}},{"id":1564116,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2024-03-22T22:04:10.000Z","date":"2024-03-01","kind":"other","planned":false,"acquired":true,"shares":900000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The third tranche was issued on March 1, 2024 and was due 18 months after the Company obtained the requisite financing. The remaining tranche is due September 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The third tranche was issued on March 1, 2024 and was due 18 months after the Company obtained the requisite financing. The remaining tranche is due September 2024."}],"balance_after":2700000,"derivative":{"exercise_price":0.3,"exercise_date":"2024-03-01","expiration_date":"2027-03-01","underlying":"Common shares","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001477932-24-001435","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793224001435/form4.xml","form_type":"4"}},{"id":1564115,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2024-03-22T22:04:10.000Z","date":"2024-03-01","kind":"other","planned":false,"acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The third tranche was issued on March 1, 2024 and was due 18 months after the Company obtained the requisite financing. The remaining tranche is due September 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The third tranche was issued on March 1, 2024 and was due 18 months after the Company obtained the requisite financing. The remaining tranche is due September 2024."}],"balance_after":5965357,"source":{"system":"sec-edgar","filing":"0001477932-24-001435","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793224001435/form4.xml","form_type":"4"}},{"id":1718333,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-12-08T16:24:29.000Z","date":"2023-12-01","kind":"other","planned":false,"acquired":false,"shares":1642500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100."}],"balance_after":0,"derivative":{"exercise_price":0.12,"exercise_date":"2023-12-01","expiration_date":"2023-12-01","underlying":"Common shares","underlying_shares":1642500},"source":{"system":"sec-edgar","filing":"0001477932-23-009031","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223009031/form4.xml","form_type":"4"}},{"id":1718332,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-12-08T16:24:29.000Z","date":"2023-11-16","kind":"other","planned":false,"acquired":true,"shares":1642500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100."}],"balance_after":1642500,"derivative":{"exercise_price":0.12,"exercise_date":"2023-11-16","expiration_date":"2023-12-01","underlying":"Common shares","underlying_shares":1642500},"source":{"system":"sec-edgar","filing":"0001477932-23-009031","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223009031/form4.xml","form_type":"4"}},{"id":1718331,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-12-08T16:24:29.000Z","date":"2023-11-16","kind":"other","planned":false,"acquired":false,"shares":950000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100."}],"balance_after":0,"derivative":{"exercise_price":0.25,"exercise_date":"2022-12-01","expiration_date":"2024-01-01","underlying":"Common shares","underlying_shares":950000},"source":{"system":"sec-edgar","filing":"0001477932-23-009031","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223009031/form4.xml","form_type":"4"}},{"id":1718330,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-12-08T16:24:29.000Z","date":"2023-11-16","kind":"other","planned":false,"acquired":false,"shares":875000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100."}],"balance_after":0,"derivative":{"exercise_price":0.25,"exercise_date":"2022-07-01","expiration_date":"2023-12-31","underlying":"Common shares","underlying_shares":875000},"source":{"system":"sec-edgar","filing":"0001477932-23-009031","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223009031/form4.xml","form_type":"4"}},{"id":1718329,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2023-12-08T16:24:29.000Z","date":"2023-12-01","kind":"other","planned":false,"acquired":true,"shares":1642500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100."}],"balance_after":5565357,"source":{"system":"sec-edgar","filing":"0001477932-23-009031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223009031/form4.xml","form_type":"4"}},{"id":1776465,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-09-20T21:49:52.000Z","date":"2023-09-01","kind":"other","planned":false,"acquired":true,"shares":900000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr.Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The second tranche was issued on September 1, 2023 and was due 12 months after the Company obtained the requisite financing. The remaining two tranches are due in six-month installments until the final tranche is issued in September 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr.Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The second tranche was issued on September 1, 2023 and was due 12 months after the Company obtained the requisite financing. The remaining two tranches are due in six-month installments until the final tranche is issued in September 2024."}],"balance_after":1800000,"derivative":{"exercise_price":0.3,"exercise_date":"2023-09-01","expiration_date":"2026-09-01","underlying":"Common Shares","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001477932-23-006982","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223006982/form4.xml","form_type":"4"}},{"id":1776464,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2023-09-20T21:49:52.000Z","date":"2023-09-01","kind":"other","planned":false,"acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr.Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The second tranche was issued on September 1, 2023 and was due 12 months after the Company obtained the requisite financing. The remaining two tranches are due in six-month installments until the final tranche is issued in September 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr.Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The second tranche was issued on September 1, 2023 and was due 12 months after the Company obtained the requisite financing. The remaining two tranches are due in six-month installments until the final tranche is issued in September 2024."}],"balance_after":3922857,"source":{"system":"sec-edgar","filing":"0001477932-23-006982","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223006982/form4.xml","form_type":"4"}},{"id":1776463,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2023-09-20T21:49:52.000Z","date":"2023-08-21","kind":"other","planned":false,"acquired":true,"shares":104914,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued for payment of accrued dividends on WMB Pension Plan's Series E preferred stock, at a conversion price of $0.1777. WMB Pension Plan is beneficially owned by Rick Blumberg, the reporting individual."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued for payment of accrued dividends on WMB Pension Plan's Series E preferred stock, at a conversion price of $0.1777. WMB Pension Plan is beneficially owned by Rick Blumberg, the reporting individual."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares were issued for payment of accrued dividends on WMB Pension Plan's Series E preferred stock, at a conversion price of $0.1777. WMB Pension Plan is beneficially owned by Rick Blumberg, the reporting individual."}],"balance_after":3522857,"source":{"system":"sec-edgar","filing":"0001477932-23-006982","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223006982/form4.xml","form_type":"4"}},{"id":1843743,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-06-27T16:02:56.000Z","date":"2023-03-01","kind":"other","planned":false,"acquired":true,"shares":900000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches, the first of which was issued on March 1, 2023 and was due 6 months after the Company obtained the requisite financing. The remaining tranches are due in six-month installments until the final tranche is issued in September 2024."}],"balance_after":900000,"derivative":{"exercise_price":0.3,"exercise_date":"2023-03-01","expiration_date":"2026-03-01","underlying":"Common Shares","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001477932-23-004807","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223004807/form4.xml","form_type":"4"}},{"id":1843742,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-06-27T16:02:56.000Z","date":"2023-02-22","kind":"other","planned":false,"acquired":false,"shares":831250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250."}],"balance_after":0,"derivative":{"exercise_price":0.2,"exercise_date":"2023-02-22","expiration_date":"2023-03-15","underlying":"Common shares","underlying_shares":831250},"source":{"system":"sec-edgar","filing":"0001477932-23-004807","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223004807/form4.xml","form_type":"4"}},{"id":1843741,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-06-27T16:02:56.000Z","date":"2023-02-22","kind":"other","planned":false,"acquired":true,"shares":831250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250."}],"balance_after":831250,"derivative":{"exercise_price":0.2,"exercise_date":"2023-02-22","expiration_date":"2023-03-15","underlying":"Common shares","underlying_shares":831250},"source":{"system":"sec-edgar","filing":"0001477932-23-004807","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223004807/form4.xml","form_type":"4"}},{"id":1843740,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-06-27T16:02:56.000Z","date":"2023-02-15","kind":"other","planned":false,"acquired":false,"shares":875000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250."}],"balance_after":1825000,"derivative":{"exercise_price":0.25,"exercise_date":"2021-02-22","expiration_date":"2023-02-22","underlying":"Common shares","underlying_shares":875000},"source":{"system":"sec-edgar","filing":"0001477932-23-004807","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223004807/form4.xml","form_type":"4"}},{"id":1843739,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2023-06-27T16:02:56.000Z","date":"2023-03-31","kind":"other","planned":false,"acquired":true,"shares":76978,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series F and Series F-2 preferred stock, at a conversion price of $0.2712."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series F and Series F-2 preferred stock, at a conversion price of $0.2712."}],"balance_after":3417943,"source":{"system":"sec-edgar","filing":"0001477932-23-004807","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223004807/form4.xml","form_type":"4"}},{"id":1843738,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2023-06-27T16:02:56.000Z","date":"2023-03-15","kind":"other","planned":false,"acquired":true,"shares":831250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250."}],"balance_after":3340965,"source":{"system":"sec-edgar","filing":"0001477932-23-004807","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223004807/form4.xml","form_type":"4"}},{"id":1843737,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2023-06-27T16:02:56.000Z","date":"2023-03-01","kind":"other","planned":false,"acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches, the first of which was issued on March 1, 2023 and was due 6 months after the Company obtained the requisite financing. The remaining tranches are due in six-month installments until the final tranche is issued in September 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches, the first of which was issued on March 1, 2023 and was due 6 months after the Company obtained the requisite financing. The remaining tranches are due in six-month installments until the final tranche is issued in September 2024."}],"balance_after":2509715,"source":{"system":"sec-edgar","filing":"0001477932-23-004807","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223004807/form4.xml","form_type":"4"}},{"id":1843736,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2023-06-27T16:01:35.000Z","date":"2023-02-10","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"One-fourth of the shares subject to the award vested on February 10, 2023; the remaining shares will vest monthly, following 90 days from the grant date, subject to the reporting person's continued service on each such date, until the award is fully vested on February 10, 2026."}],"balance_after":100000,"derivative":{"exercise_price":0.26,"exercise_date":"2023-02-10","expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001477932-23-004806","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223004806/form4.xml","form_type":"4"}},{"id":1843735,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-06-27T16:00:45.000Z","date":"2022-12-01","kind":"other","planned":false,"acquired":true,"shares":950000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 30, 2021, the Company entered into a Consulting Agreement with Richard Blumberg pursuant to which the Company agreed to issue 950,000 warrants to purchase an aggregate of 950,000 shares of common stock for $0.25 per share. Issuance of the warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The Company obtained the requisite financing and the warrants were issued on December 1, 2022. The warrants will expire on January 1, 2024 if they are not exercised."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 30, 2021, the Company entered into a Consulting Agreement with Richard Blumberg pursuant to which the Company agreed to issue 950,000 warrants to purchase an aggregate of 950,000 shares of common stock for $0.25 per share. Issuance of the warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The Company obtained the requisite financing and the warrants were issued on December 1, 2022. The warrants will expire on January 1, 2024 if they are not exercised."}],"balance_after":2700000,"derivative":{"exercise_price":0.25,"exercise_date":"2022-12-01","expiration_date":"2024-01-01","underlying":"Common shares","underlying_shares":950000},"source":{"system":"sec-edgar","filing":"0001477932-23-004805","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223004805/form4.xml","form_type":"4"}},{"id":1843734,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-06-27T15:59:48.000Z","date":"2022-09-01","kind":"purchase","planned":false,"acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 1, 2022, the Company entered into a Securities Purchase Agreements with Mr. Blumberg pursuant to which the Company issued 1,000,000 shares of its common stock, four-year warrants to purchase an aggregate of 1,000,000 shares of common stock for $0.50 per share and four-year warrants to purchase 1,000,000 shares of common stock for $0.65 per share for an aggregate purchase price of $500,000."}],"balance_after":1000000,"derivative":{"exercise_price":0.65,"exercise_date":"2022-09-01","expiration_date":"2026-09-01","underlying":"Common shares","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001477932-23-004804","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223004804/form4.xml","form_type":"4"}},{"id":1843733,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-06-27T15:59:48.000Z","date":"2022-09-01","kind":"purchase","planned":false,"acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 1, 2022, the Company entered into a Securities Purchase Agreements with Mr. Blumberg pursuant to which the Company issued 1,000,000 shares of its common stock, four-year warrants to purchase an aggregate of 1,000,000 shares of common stock for $0.50 per share and four-year warrants to purchase 1,000,000 shares of common stock for $0.65 per share for an aggregate purchase price of $500,000."}],"balance_after":1000000,"derivative":{"exercise_price":0.5,"exercise_date":"2022-09-01","expiration_date":"2026-09-01","underlying":"Common shares","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001477932-23-004804","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223004804/form4.xml","form_type":"4"}},{"id":1843732,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":49758,"kind":"person","name":"Blumberg Richard P.","position":1,"cik":"0001486345","reported_name":"Blumberg Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-27T15:59:48.000Z","date":"2022-09-02","kind":"purchase","planned":false,"acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 1, 2022, the Company entered into a Securities Purchase Agreements with Mr. Blumberg pursuant to which the Company issued 1,000,000 shares of its common stock, four-year warrants to purchase an aggregate of 1,000,000 shares of common stock for $0.50 per share and four-year warrants to purchase 1,000,000 shares of common stock for $0.65 per share for an aggregate purchase price of $500,000."}],"balance_after":2109715,"source":{"system":"sec-edgar","filing":"0001477932-23-004804","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223004804/form4.xml","form_type":"4"}}]}